NIACIN EXTENDED-RELEASE TABLETS. Key specifications include administration: ORAL, long_action_method: EXTENDED RELEASE, primary_container_type: BOTTLE, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 500.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: NIACIN EXTENDED RELEASE TABLETS 500 MG BT 100S. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-524-9144, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| long_action_method | EXTENDED RELEASE |
| primary_container_type | BOTTLE |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 500.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | NIACIN EXTENDED RELEASE TABLETS 500 MG BT 100S |
| american_hospital_formulary_service_classification_number | 240692 |
| NSN | 6505-01-524-9144 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| ADMINISTRATION | ORAL |
| SPECIAL FEATURES | SUSTAINED ACTION NIACIN TABLETS; ITEM IS USED AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TC, LDL-C, APO B AND TG LEVELS, AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA WHEN THE RESPONSE TO AN APPROPRIATE DIET HAS BEEN INADEQUATE; STORE AT ROOM TEMPERATURE (20 TO 25 DEGREES C OR 68 TO 77 DEGREES F) |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | NIACIN EXTENDED RELEASE TABLETS 500 MG BT 100S |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 240692 |
| PRIMARY CONTAINER TYPE | BOTTLE |
| LONG ACTION METHOD | EXTENDED RELEASE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |